Nigerian writer Chimamanda says hospital delaying son's inquest

AFP
By AFP June 14, 2026 10:00 (EAT)
Add as a Preferred Source on Google
Nigerian writer Chimamanda says hospital delaying son's inquest
Vocalize Pre-Player Loader

Audio By Vocalize

Nigerian bestselling novelist Chimamanda Ngozi Adichie on Saturday accused a Lagos hospital of attempting to obstruct an inquest into the death of her 21-month-old son at the facility six months ago.

Nkanu Nnamdi died on January 7 at Euracare Multispecialist Hospital, where he had been taken for diagnostic tests including MRI before he was due to travel to the United States for specialised care.

The post on her Instagram page was her first public comment since the death.

Adichie who lives in the United States but was in Nigeria for the Christmas holidays published a letter she wrote to the hospital, dated April 16.

In it, she wrote: "to have Nkanu gone so cruelly, so unfairly, so carelessly, had brought an inexpressible pain."

The coroner's inquest had been due to open on April 14, she wrote on Saturday.

"Instead Euracare decided to deploy delaying tactics," she added.

"It was Euracare which first applied for an inquest in January, stating that our son's death was unexpected and an inquest was in their interest because of 'rumours of negligence.'"

"Yet they have stalled and muddied and obfuscated. If this is how Euracare manages a crisis, it is little wonder it mismanaged our precious son's care."

AFP has reached out to Euracare for comment.

In her letter, she said the medical director had told her that the anaesthesiologist had given her son "'too much propofol'" to sedate him during the MRI scan, which had caused "respiratory and cardiac arrest".

She said the hospital had issued a death certificate claiming her son had died from meningitis.

The hospital has previously denied any wrongdoing.

The boy's death reignited debates about the poor state of Nigeria's healthcare system.

Join the Discussion

Share your perspective with the Citizen Digital community.

Moderation applies

Sign In to Publish

No comments yet

This discussion is waiting for your voice. Be the first to share your thoughts!